Published in Br J Cancer on February 01, 2001
Soft tissue tumors associated with EWSR1 translocation. Virchows Arch (2010) 1.50
Caffeine-potentiated chemotherapy for clear cell sarcoma: a report of five cases. Int J Clin Oncol (2011) 1.40
Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J Mol Diagn (2002) 1.15
Primary clear cell sarcoma of rib. Skeletal Radiol (2004) 0.99
Primary clear cell sarcoma of humerus: case report. World J Surg Oncol (2011) 0.89
Primary clear cell sarcoma (malignant melanoma) in the right radius. Skeletal Radiol (2003) 0.86
MR appearance of clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts): radiologic-pathologic correlation. Skeletal Radiol (2005) 0.84
Clear cell sarcoma of the soft parts arising in the rectus abdominis in a child - aspiration cytology of a rare case. Cytojournal (2007) 0.83
Primary clear cell sarcoma of the sacrum: a case report. Skeletal Radiol (2010) 0.81
Molecular genetics of pediatric soft tissue tumors: clinical application. J Mol Diagn (2003) 0.79
Clinicopathological features, diagnosis and treatment of clear cell sarcoma/melanoma of soft parts. Hippokratia (2013) 0.79
A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant. BMC Cancer (2012) 0.77
Malignant melanoma of soft parts with osteoclast-rich giant cells: A rare tumour of the jejunum. Australas Med J (2014) 0.76
Simultaneous Clear Cell Sarcomas of the Duodenum and Jejunum. Case Rep Med (2016) 0.76
Multiple clear-cell sarcomas of small intestine with parotid gland metastasis: A case report. World J Gastroenterol (2017) 0.75
CLEAR-CELL SARCOMA OF TENDONS AND APONEUROSES. AN ANALYSIS OF 21 CASES. Cancer (1965) 3.12
EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet (1993) 2.72
Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med (1991) 1.99
Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol (1983) 1.95
Establishment and characterization of an uveal-melanoma cell line. Int J Cancer (1995) 1.59
Clear cell sarcoma with t(12;22) (q13-14;q12). Genes Chromosomes Cancer (1991) 1.53
The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol (1995) 1.30
MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review. Skeletal Radiol (2000) 1.21
Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation. Mod Pathol (1997) 1.02
Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood (1996) 1.01
Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors. J Am Acad Dermatol (2000) 0.97
Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis. Am J Clin Pathol (1990) 0.91
Nonrandom chromosome structural aberrations and oncogene loci in human malignant melanoma. Cancer Genet Cytogenet (1986) 0.91
Reciprocal translocation t(12;22)(q13;q13) in clear-cell sarcoma of tendons and aponeuroses. Genes Chromosomes Cancer (1992) 0.90
Clear-cell sarcoma of tendons and aponeuroses. An immunohistochemical and electron microscopic analysis indicating neural crest origin. Virchows Arch A Pathol Anat Histopathol (1983) 0.89
Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours. J Clin Pathol (1999) 0.88
Use of a newly established human cell line (SU-CCS-1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma. Cancer Res (1984) 0.87
Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts. Cancer Genet Cytogenet (1991) 0.86
Genes involved in melanoma: an overview of INK4a and other loci. Melanoma Res (1999) 0.86
Keratin immunoreactivity in melanoma of soft parts (clear cell sarcoma). Histopathology (1995) 0.85
Clear cell sarcoma of tendons and aponeuroses with t(12;22) (q13;q12) diagnosed initially as malignant melanoma. Cancer Genet Cytogenet (1996) 0.84
Significance of both numerical and structural chromosomal abnormalities in clear cell sarcoma. Cancer Genet Cytogenet (1992) 0.83
Translocation (12;22)(q13-14;q12) is a nonrandom aberration in soft-tissue clear-cell sarcoma. Genes Chromosomes Cancer (1992) 0.83
Translocation t(12;22)(q13;q13) is a nonrandom rearrangement in clear cell sarcoma. Cancer Genet Cytogenet (1992) 0.81
Malignant melanoma of soft parts. Further cytogenetic characterization. Cancer Genet Cytogenet (1992) 0.80
Translocation t(12;22)(q13;q12.2-12.3) in a clear cell sarcoma of tendons and aponeuroses. Genes Chromosomes Cancer (1993) 0.80
t(12;22)(q13;q13) and trisomy 8 are nonrandom aberrations in clear-cell sarcoma. Cancer Genet Cytogenet (1992) 0.80
Aberrations of chromosome 22 and polysomy of chromosome 8 as non-random changes in clear cell sarcoma. Cancer Genet Cytogenet (1994) 0.78
Micrometastases and survival in stage II colorectal cancer. N Engl J Med (1998) 5.11
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J (1995) 4.55
E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene (1996) 3.35
Myxoid tumours of soft tissue. Histopathology (1999) 2.53
Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet (1994) 2.45
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol (1997) 2.15
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer (1997) 2.02
Ever since Knudson. Trends Genet (2001) 1.96
Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol (1999) 1.81
PCR artifacts in LOH and MSI analysis of microdissected tumor cells. Hum Pathol (2000) 1.77
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet (1999) 1.70
Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Lab Invest (2000) 1.62
Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma. AJR Am J Roentgenol (1997) 1.61
The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol (2001) 1.60
Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas. Eur J Cancer (2004) 1.58
Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature. Cancer (1999) 1.54
Nora's lesion, a distinct radiological entity? Skeletal Radiol (2006) 1.52
The glomerular deposition of PAS positive material correlates with renal function in human kidney diseases. Clin Nephrol (1997) 1.48
Structural organization and regulation of the small proline-rich family of cornified envelope precursors suggest a role in adaptive barrier function. J Biol Chem (2001) 1.43
Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma. Genes Chromosomes Cancer (1999) 1.37
High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma. J Clin Pathol (2001) 1.33
Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia (1999) 1.32
Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior. J Bone Joint Surg Am (1994) 1.31
Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology (2000) 1.28
MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review. Skeletal Radiol (2000) 1.21
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res (1994) 1.21
Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol (1988) 1.18
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type. Br J Cancer (1999) 1.17
Adenocarcinoma arising within a tailgut cyst: clinicopathological description and follow up of an unusual case. J Clin Pathol (1999) 1.17
Retroperitoneal extraskeletal osteosarcoma. J Clin Pathol (2001) 1.14
Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR Am J Roentgenol (1995) 1.11
Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases. Genes Chromosomes Cancer (2000) 1.10
Pathology of primary malignant bone and cartilage tumours. Int Orthop (2006) 1.07
Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response. Hum Pathol (1996) 1.06
Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings. Radiology (1993) 1.06
Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin Exp Immunol (1990) 1.05
The genomic organization of the Fanconi anemia group A (FAA) gene. Genomics (1997) 1.05
Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma. Am J Pathol (2000) 1.05
Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study. J Clin Oncol (1999) 1.05
[Imatinib, a specific tyrosine-kinase inhibitor, for the treatment of patients with a gastrointestinal stroma cell tumor]. Ned Tijdschr Geneeskd (2003) 1.04
Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization? Radiology (1998) 1.03
Accuracy of the Jamshidi trocar biopsy in the diagnosis of bone tumors. Clin Orthop Relat Res (1997) 1.03
Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities. Skeletal Radiol (1998) 1.02
Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance. Ann Oncol (2011) 1.02
Lymph node staging standards in gastric cancer. J Clin Oncol (1995) 1.01
Cytogenetic analysis of adamantinoma of long bones: further indications for a common histogenesis with osteofibrous dysplasia. Cancer Genet Cytogenet (1997) 1.00
Cisplatin effects on F-actin and matrix proteins precede renal tubular cell detachment and apoptosis in vitro. Cell Death Differ (1998) 1.00
The extracellular matrix in pathology. J Lab Clin Med (1988) 0.99
Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis. Rheumatology (Oxford) (2001) 0.98
Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissues: a comparison of various antigen retrieval systems using microwave heating and proteolytic pre-treatments. J Histochem Cytochem (1995) 0.98
Soft tissue tumours of the retroperitoneum. Sarcoma (2000) 0.97
Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes. Diagn Mol Pathol (2001) 0.96
Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer. Genomics (1998) 0.95
Malignant progression in multiple enchondromatosis (Ollier's disease): an autopsy-based molecular genetic study. Hum Pathol (2000) 0.95
Myxoid tumours of soft tissue: the so-called myxoid extracellular matrix is heterogeneous in composition. Histopathology (2008) 0.94
Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis. Lab Invest (1990) 0.94
ECM homeostasis in renal diseases: a genomic approach. J Pathol (2003) 0.93
Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas. Cancer Res (1993) 0.92
Expression of growth factors and their receptors in adamantinoma of long bones and the implication for its histogenesis. J Pathol (1998) 0.92
Retain or sacrifice the posterior cruciate ligament in total knee arthroplasty? A histopathological study of the cruciate ligament in osteoarthritic and rheumatoid disease. J Clin Pathol (2001) 0.92
The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2. Eur J Hum Genet (1996) 0.91
A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1. Genes Chromosomes Cancer (2000) 0.91
A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma. European Osteosarcoma Intergroup (EOI). Ann Oncol (1999) 0.91
Molecular detection of minimal residual disease in colorectal and breast cancer. Histopathology (1999) 0.91
The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer. Genomics (1999) 0.90
Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging (1997) 0.90
Re. Review article entitled 'The neoplastic pathogenesis of solitary and multiple osteochondromas'. J Pathol (2000) 0.90
Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol (1995) 0.90
Adamantinoma of the long bones: keratin subclass immunoreactivity pattern with reference to its histogenesis. Am J Surg Pathol (1993) 0.89
MR imaging based strategies in limb salvage surgery for osteosarcoma of the distal femur. Skeletal Radiol (1997) 0.89
Late malignant transformation of a benign giant-cell tumor of bone. A case report. J Bone Joint Surg Am (1997) 0.89
Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes. Br J Cancer (1997) 0.88
Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours. J Clin Pathol (1999) 0.88
Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancer. Genomics (1998) 0.88
Primary intraosseous manifestation of Rosai-Dorfman disease: 2 cases and review of literature. JBR-BTR (2014) 0.87
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium. Genes Chromosomes Cancer (1999) 0.87
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery. Br J Cancer (2013) 0.87
Molecular evidence of field cancerization in a patient with 7 tumors of the aerodigestive tract. Hum Pathol (2000) 0.87
Cytokine profile of cervical cancer cells. Gynecol Oncol (2001) 0.85
Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol (1995) 0.85
Local recurrence of a phyllodes tumour of the breast presenting with widespread differentiation to a telangiectatic osteosarcoma. J Clin Pathol (1998) 0.85
Keratin immunoreactivity in melanoma of soft parts (clear cell sarcoma). Histopathology (1995) 0.85
Genomic structure and expression analysis of the spastic paraplegia gene, SPG7. Hum Genet (1999) 0.84
Gender-related influences on the development of chronic graft-versus-host disease-induced experimental lupus nephritis. Clin Exp Immunol (1993) 0.83
Synovial sarcoma: dynamic contrast-enhanced MR imaging features. Skeletal Radiol (2001) 0.83
Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imaging. Skeletal Radiol (1994) 0.82
Absence of Epstein-Barr virus (EBV) in a gastrointestinal stromal cell tumour (GIST) in an adult human immunodeficiency virus-seropositive patient with past EBV infection. Eur J Gastroenterol Hepatol (1997) 0.82
Adamantinoma-like Ewing's sarcoma and Ewing's-like adamantinoma. The t(11; 22), t(21; 22) status. J Pathol (2001) 0.82
Chondroblastic osteosarcoma: characterisation by gadolinium-enhanced MR imaging correlated with histopathology. Skeletal Radiol (1998) 0.82
How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone? Cancer Lett (1998) 0.82
DNA aberrations in the epithelial cell component of adamantinoma of long bones. Am J Pathol (1995) 0.81
An association between cartilaginous tumours and breast cancer in the national pathology registration in The Netherlands points towards a possible genetic trait. J Pathol (2001) 0.81